Literature DB >> 1586135

Cytokine expression in the brain during the acquired immunodeficiency syndrome.

W R Tyor1, J D Glass, J W Griffin, P S Becker, J C McArthur, L Bezman, D E Griffin.   

Abstract

The pathogenesis of central nervous system (CNS) disease in acquired immunodeficiency syndrome (AIDS) is poorly understood but may be related to specific effects of the immune system. Cytokines such as tumor necrosis factor and interleukin-1 may have toxic effects on CNS cells and have been postulated to contribute to the pathogenesis of the neurological complications of human immunodeficiency virus (HIV) infection. To characterize viral and immunological activity in the CNS, frozen specimens taken at autopsy from the cerebral cortex and white matter of HIV-seropositive and -seronegative individuals were stained immunocytochemically for mononuclear cells, major histocompatibility complex (MHC) antigens, HIV, astrocytes, and the cytokines interleukin-1 and -6, tumor necrosis factor-alpha and -beta, and interferon gamma. Levels of soluble CD4, CD8, and interleukin-2 receptor, as well as interferon gamma, tumor necrosis factor-alpha, beta 2-microglobulin, neopterin, and interleukin-6 and -1 beta were assayed in the cerebrospinal fluid and plasma of many of these individuals during life. The HIV-seropositive group included individuals without neurological disease, those with CNS opportunistic infections, and those with HIV encephalopathy. Perivascular cells, consisting primarily of macrophages with some CD4+ and CD8+ T cells and rare B cells, were consistently MHC class II positive. MHC class II antigen was also present on microglial cells, which were frequently positive for tumor necrosis factor-alpha. HIV p24 antigen, when present, was found on macrophages and microglia. Endothelial cells were frequently positive for interleukin-1 and interferon gamma and less frequently for tumor necrosis factor and interleukin-6. There were gliosis and significant increases in MHC class II antigen, interleukin-1, and tumor necrosis factor-alpha in HIV-positive patients compared to HIV-negative brains. Cerebrospinal fluid from most of the patients tested had increased levels of tumor necrosis factor, beta 2-microglobulin, and neopterin. There was no correlation in HIV-positive individuals between levels of cytokines and the presence or absence of CNS disease. These data indicate that there is a relative state of "immune activation" in the brains of HIV-positive compared to HIV-negative individuals, and suggest a potential role for the immune system in the pathogenesis of HIV encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586135     DOI: 10.1002/ana.410310402

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  160 in total

1.  Acute multiple sclerosis characterized by extensive mononuclear phagocyte infiltration.

Authors:  D C Shields; N G Avgeropoulos; N L Banik; W R Tyor
Journal:  Neurochem Res       Date:  2000-11       Impact factor: 3.996

Review 2.  Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.

Authors:  E M Frohman; N L Monson; A E Lovett-Racke; M K Racke
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

3.  Characterization of an in vitro rhesus macaque blood-brain barrier.

Authors:  Andrew G MacLean; Marlene S Orandle; John MacKey; Kenneth C Williams; Xavier Alvarez; Andrew A Lackner
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

4.  MCP-3/CCL7 production by astrocytes: implications for SIV neuroinvasion and AIDS encephalitis.

Authors:  Nicole A Renner; Nathan S Ivey; Rachel K Redmann; Andrew A Lackner; Andrew G MacLean
Journal:  J Neurovirol       Date:  2011-01-29       Impact factor: 2.643

5.  Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions.

Authors:  L A Boven; L Montagne; H S Nottet; C J De Groot
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

6.  An early increase in somatostatin mRNA expression in the frontal cortex of rhesus monkeys infected with simian immunodeficiency virus.

Authors:  A Da Cunha; D M Rausch; L E Eiden
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia.

Authors:  I P Everall; J D Glass; J McArthur; E Spargo; P Lantos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: implications for AIDS dementia complex.

Authors:  D J Benos; B H Hahn; J K Bubien; S K Ghosh; N A Mashburn; M A Chaikin; G M Shaw; E N Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

9.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha.

Authors:  L Probert; K Akassoglou; M Pasparakis; G Kontogeorgos; G Kollias
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.